ASH Precision Medicine Initiative
Precision medicine encompasses all approaches that use patient- and disease-specific information to prevent, diagnose, and treat a disease. The increasingly widespread use of genome sequencing and genomic profiling has significantly improved the diagnoses and treatment of hematologic diseases by identifying unique variants that can be targeted with gene-based targeted therapeutic approaches including immunotherapies.
Applying the principles of precision medicine to hematologic diseases is a priority for ASH, and specific research recommendation are described in more detail in the ASH Agenda for Hematology Research.
Learn more about ASH's Precision Medicine Initiative activities:
back to top